IDO1 and central nervous system cancer: Moreover, Kaplan–Meier survival analysis of patients with glioma from TCGA and CGGA databases revealed that OS was significantly lower for patients with IDO1-high expression than for those with IDO1-low expression (Fig. 1F, G).